Cerebroprotein hydrolysate: Innovation in the treatment of neurodegenerative disorders

Abstract

Neurodegenerative disorders are one of the leading causes of death and disability in both developing and developed countries. There are a number of neurotrophic drugs used in these disorders. Cerebroprotein hydrolysate is the latest one launched in more than 40 countries. Its superiorty is because of different actions which help in faster and more complete nerve repair and growth than other neurotrophic agents. Different mechanisms include regulation and improvement of the neuronal metabolism, modulation of the synaptic plasticity, neuronal differentiation and protection against ischaemic and neurotoxic lesions, cerebroprotein hydrolysate reduces excitotoxic damage, blocks over-activation of calcium dependent proteases, and scavenges free oxygen radicals.